Massive Splenomegaly with Pancytopenia in an Adult: Gaucher's Disease.

Farid Alam, Jitendra Singh, Nilesh Kumar, Kailash Kumar, Anju Dinkar
{"title":"Massive Splenomegaly with Pancytopenia in an Adult: Gaucher's Disease.","authors":"Farid Alam, Jitendra Singh, Nilesh Kumar, Kailash Kumar, Anju Dinkar","doi":"10.2174/011871529X253966230922110202","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Gaucher's disease (GD) is a rare lysosomal storage disease. It is characterized by the deposition of glucocerebroside in cells of the macrophage-monocyte system. GD presents a broad clinical expression, including hematologic abnormalities (such as pancytopenia), massive hepatosplenomegaly, diffuse infiltrative pulmonary disease, renal involvement in the form of nephropathy and glomerulonephritis, skeletal involvement in the form of bone pain, bony infarct, osteopenia, and pathological fracture. Based on the presence or absence of neurologic involvement, it is differentiated into type 1, type 2, and type 3. Gaucher's disease type 1 is the most common form, having the nonneuropathic form and carrying autosomal recessive traits. Gaucher's disease affects all racial and ethnic groups, while type 1 GD is most prevalent among Ashkenazi Jews.</p><p><strong>Case presentation: </strong>A 20-year-old female was admitted to the medicine department with complaints of generalized weakness and easy fatigability, menorrhagia, and a dragging sensation in the abdomen. On clinical evaluation, she had bone marrow failure syndrome features along with massive splenomegaly. Later, she was confirmed with Gaucher disease type 1 disease by clinical and investigation (low β-glucosidase level) evaluation.</p><p><strong>Conclusion: </strong>This case emphasizes keeping a differential diagnosis of glycogen storage disorder while evaluating a case of unexplained pancytopenia with massive splenomegaly in adulthood for an extended period. Currently, enzyme replacement therapy and substrate reduction therapy are the mainstay therapeutic options for GD.</p>","PeriodicalId":93925,"journal":{"name":"Cardiovascular & hematological disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular & hematological disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/011871529X253966230922110202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Gaucher's disease (GD) is a rare lysosomal storage disease. It is characterized by the deposition of glucocerebroside in cells of the macrophage-monocyte system. GD presents a broad clinical expression, including hematologic abnormalities (such as pancytopenia), massive hepatosplenomegaly, diffuse infiltrative pulmonary disease, renal involvement in the form of nephropathy and glomerulonephritis, skeletal involvement in the form of bone pain, bony infarct, osteopenia, and pathological fracture. Based on the presence or absence of neurologic involvement, it is differentiated into type 1, type 2, and type 3. Gaucher's disease type 1 is the most common form, having the nonneuropathic form and carrying autosomal recessive traits. Gaucher's disease affects all racial and ethnic groups, while type 1 GD is most prevalent among Ashkenazi Jews.

Case presentation: A 20-year-old female was admitted to the medicine department with complaints of generalized weakness and easy fatigability, menorrhagia, and a dragging sensation in the abdomen. On clinical evaluation, she had bone marrow failure syndrome features along with massive splenomegaly. Later, she was confirmed with Gaucher disease type 1 disease by clinical and investigation (low β-glucosidase level) evaluation.

Conclusion: This case emphasizes keeping a differential diagnosis of glycogen storage disorder while evaluating a case of unexplained pancytopenia with massive splenomegaly in adulthood for an extended period. Currently, enzyme replacement therapy and substrate reduction therapy are the mainstay therapeutic options for GD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
成人脾肿大伴全血细胞减少:戈谢病。
引言:戈谢病(GD)是一种罕见的溶酶体贮积性疾病。其特征是葡萄糖脑苷沉积在巨噬细胞-单核细胞系统的细胞中。GD表现为广泛的临床表现,包括血液学异常(如全血细胞减少症)、大量肝脾肿大、弥漫性浸润性肺病、肾病和肾小球肾炎形式的肾脏受累、骨痛形式的骨骼受累、骨梗死、骨质减少和病理性骨折。根据是否存在神经系统受累,可分为1型、2型和3型。1型戈谢病是最常见的形式,具有非神经性形式,并具有常染色体隐性遗传特征。戈谢病影响所有种族和民族,而1型GD在阿什肯纳兹犹太人中最为普遍。病例介绍:一名20岁的女性因全身无力、易疲劳、月经过多和腹部拖拉感而被送入内科。在临床评估中,她有骨髓衰竭综合征的特征,并伴有巨大的脾肿大。后来,通过临床和调查(低β-葡萄糖苷酶水平)评估,她被证实患有戈谢病1型疾病。结论:本病例强调对糖原储存障碍进行鉴别诊断,同时评估一例成年期不明原因全血细胞减少伴大脾肿大的病例。目前,酶替代疗法和底物还原疗法是GD的主要治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Acute Myeloid Leukemia Presenting as Extensive Arterial and Venous Thrombosis: A Case Report. Inter-atrial Septum Stenting in Congenital Heart Disease Patient: A Case Series in Indonesia. Exploring the Role of Secondary Metabolites from Plants and Microbes as Modulators of Macrophage Differentiation. Dengue Fever Related Reactive Thrombocytosis in Young Male: A Case Report and Review Literature. Toll-like Receptors: Therapeutic Potential in Life Threatening Diseases-Cardiac Disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1